Share of people with HIV who receive antiretroviral therapy in Serbia
Serbia: Share of people with HIV who receive antiretroviral therapy was 65.0% in 2024. ▲ Rising
Share of people with HIV who receive antiretroviral therapy in Serbia, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Serbia recorded 65.0% for share of people with hiv who receive antiretroviral therapy in 2024. That is the highest value across all 25 years on record.
The figure is up 35.4% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Serbia peaked at 65.0% in 2023 and was at its lowest, 0.0%, in 2000.
Serbia ranks 93rd of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Share of people with HIV who receive antiretroviral therapy in Serbia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 28.0% | — |
| 2004 | 35.0% | +25.0% |
| 2005 | 42.0% | +20.0% |
| 2006 | 41.0% | -2.4% |
| 2007 | 41.0% | +0.0% |
| 2008 | 42.0% | +2.4% |
| 2009 | 42.0% | +0.0% |
| 2010 | 44.0% | +4.8% |
| 2011 | 45.0% | +2.3% |
| 2012 | 45.0% | +0.0% |
| 2013 | 46.0% | +2.2% |
| 2014 | 48.0% | +4.3% |
| 2015 | 50.0% | +4.2% |
| 2016 | 53.0% | +6.0% |
| 2017 | 57.0% | +7.5% |
| 2018 | 61.0% | +7.0% |
| 2019 | 62.0% | +1.6% |
| 2020 | 62.0% | +0.0% |
| 2021 | 63.0% | +1.6% |
| 2022 | 64.0% | +1.6% |
| 2023 | 65.0% | +1.6% |
| 2024 | 65.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 27.1% | 0.0% | 42.0% | 10 |
| 2010s | 51.1% | 44.0% | 62.0% | 10 |
| 2020s | 63.8% | 62.0% | 65.0% | 5 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Population ages 60-64, female, annual growth rate -2.29 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.036 units per person (2025)
- Population ages 60-64, male, annual growth rate -2.22 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.031 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Serbia?
- Share of people with hiv who receive antiretroviral therapy in Serbia was 65.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Serbia?
- The highest recorded value was 65.0% in 2023.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Serbia?
- The lowest recorded value was 0.0% in 2000.
- How does Serbia rank for share of people with hiv who receive antiretroviral therapy?
- Serbia ranks 93rd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Serbia?
- Over the last ten years it is up 35.4%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.